BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1633621)

  • 1. The discovery of cell wall active antibacterial antibiotics.
    Gadebusch HH; Stapley EO; Zimmerman SB
    Crit Rev Biotechnol; 1992; 12(3):225-43. PubMed ID: 1633621
    [No Abstract]   [Full Text] [Related]  

  • 2. A multivalent approach to drug discovery for novel antibiotics.
    Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
    J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the cell wall of bacteria remain a viable source of targets for novel antibiotics?
    Silver LL
    Biochem Pharmacol; 2006 Mar; 71(7):996-1005. PubMed ID: 16290173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Lactam and glycopeptide antibiotics: first and last line of defense?
    Jovetic S; Zhu Y; Marcone GL; Marinelli F; Tramper J
    Trends Biotechnol; 2010 Dec; 28(12):596-604. PubMed ID: 20970210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel disaccharide antibacterial agents using a combinatorial library approach.
    Sofia MJ; Allanson N; Hatzenbuhler NT; Jain R; Kakarla R; Kogan N; Liang R; Liu D; Silva DJ; Wang H; Gange D; Anderson J; Chen A; Chi F; Dulina R; Huang B; Kamau M; Wang C; Baizman E; Branstrom A; Bristol N; Goldman R; Han K; Longley C; Axelrod HR
    J Med Chem; 1999 Aug; 42(17):3193-8. PubMed ID: 10464005
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bacterial tolerant to antibiotics with action on the wall].
    Timoşca S; Petreanu V
    Rev Med Chir Soc Med Nat Iasi; 1983; 87(1):21-4. PubMed ID: 6676827
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibiotic sensitivity and the chemical structures of the bacterial wall].
    Shoshiev LN; Orlova GM; Makarovskaia LN
    Antibiotiki; 1980 Jun; 25(6):468-74. PubMed ID: 6994633
    [No Abstract]   [Full Text] [Related]  

  • 8. Mode of action of antibacterial agents.
    O'Grady FW
    Proc R Soc Med; 1971 May; 64(5):529-33. PubMed ID: 5576916
    [No Abstract]   [Full Text] [Related]  

  • 9. Membrane Disruption and Enhanced Inhibition of Cell-Wall Biosynthesis: A Synergistic Approach to Tackle Vancomycin-Resistant Bacteria.
    Yarlagadda V; Samaddar S; Paramanandham K; Shome BR; Haldar J
    Angew Chem Int Ed Engl; 2015 Nov; 54(46):13644-9. PubMed ID: 26473305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new series of glycopeptide antibiotics incorporating a squaric acid moiety. Synthesis, structural and antibacterial studies.
    Sztaricskai F; Batta G; Herczegh P; Balázs A; Jeko J; Roth E; Szabó PT; Kardos S; Rozgonyi F; Boda Z
    J Antibiot (Tokyo); 2006 Sep; 59(9):564-82. PubMed ID: 17136889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the positional attachment of glycopeptide/beta-lactam heterodimers.
    Long DD; Aggen JB; Chinn J; Choi SK; Christensen BG; Fatheree PR; Green D; Hegde SS; Judice JK; Kaniga K; Krause KM; Leadbetter M; Linsell MS; Marquess DG; Moran EJ; Nodwell MB; Pace JL; Trapp SG; Turner SD
    J Antibiot (Tokyo); 2008 Oct; 61(10):603-14. PubMed ID: 19168974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the antibacterial spectrum of drosocin analogues.
    Bikker FJ; Kaman-van Zanten WE; de Vries-van de Ruit AM; Voskamp-Visser I; van Hooft PA; Mars-Groenendijk RH; de Visser PC; Noort D
    Chem Biol Drug Des; 2006 Sep; 68(3):148-53. PubMed ID: 17062012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.
    Castiglione F; Cavaletti L; Losi D; Lazzarini A; Carrano L; Feroggio M; Ciciliato I; Corti E; Candiani G; Marinelli F; Selva E
    Biochemistry; 2007 May; 46(20):5884-95. PubMed ID: 17469849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Classes of antibiotics and their mechanisms of action].
    Thrum H
    Z Gesamte Inn Med; 1977 Jul; 32(14):Suppl: 209-14. PubMed ID: 919647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Focus on beta-lactam antibiotics].
    Cometta A; Glauser MP
    Schweiz Med Wochenschr; 1988 Dec; 118(49):1817-22. PubMed ID: 3064289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The properties of beta-lactam antibiotics needed for therapeutic efficacy.
    Richmond MH
    Prog Clin Biol Res; 1979; 35():17-25. PubMed ID: 317154
    [No Abstract]   [Full Text] [Related]  

  • 17. Building a bridge to new antibiotics.
    Pohl NL
    ACS Chem Biol; 2006 Feb; 1(1):14-6. PubMed ID: 17163633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bacterial cell wall as a source of antibacterial targets.
    Green DW
    Expert Opin Ther Targets; 2002 Feb; 6(1):1-19. PubMed ID: 11901475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The mechanism of action of 2 major families of antibiotics: beta-lactams and aminoglycosides. Practical consequences].
    Michel-Briand Y
    Ann Anesthesiol Fr; 1979; 20(6-7):571-6. PubMed ID: 95083
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of action of synthetic antiiotics and synthetic antibiotics resistence].
    Lattanzi A
    Omnia Med Ther; 1970; 48(1):175-84. PubMed ID: 4922694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.